Two hundred and eighty-six isolates from human clinical samples were identified between 1996 and 2019 as belonging to 8 families, 19 genera and 88 species of
Actinobacteria
. The most identified genera were
Streptomyces
(182 strains from 45 species),
Actinomadura
(29 strains, 5 species),
Nocardiopsis
(21 strains, 6 species) and
Dietzia
(18 strains, 5 species). The rest of the identified genera (15) contained 27 species with 36 isolates. Of the species studied, only 13/88 had been documented previously as isolates from clinical samples, and in some cases, as true pathogens. In this sense, a literature review of the species found in infections or in clinical samples without clear involvement in pathology has been carried out. Finally, the susceptibility to 8 antimicrobial agents has been studied.
Streptomyces
showed high resistance (80.8%) against cefotaxime and cotrimoxazole (55.5%), and no isolate resistance to amikacin and linezolid have been found. Lower percentages of resistance have been found in other genera, except in
Dietzia
(100% against cotrimoxazole and 44.4% against erythromycin). The greatest resistance in these genera was to cotrimoxazole (29.8) and erythromycin (27,9%), and no resistance to linezolid has been found in these genera. In
Microbispora, Nonomuraea and Umezawaea
, no resistant isolates have been found against any antibiotic studied. Only 3/104 isolates were resistant to amikacin in
Amycolatopsis
,
Crossiella
, and
Micromonosopora.
One isolate of
Amycolatopsis
was resistant to imipenem.